| 1 |
27939611 | High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells. | 2017 Mar |
1 |
| 2 |
25596135 | In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate. | 2015 Apr |
1 |
| 3 |
18825528 | In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048. | 2009 Jun |
1 |
| 4 |
18804659 | Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators. | 2008 Oct 19 |
1 |
| 5 |
18049927 | Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: implication for the action of acylpeptide hydrolase. | 2007 Dec |
1 |
| 6 |
14535624 | Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. | 2003 |
1 |
| 7 |
10718203 | Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group. | 2000 Jan-Mar |
2 |
| 8 |
10773217 | In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C level. | 2000 Apr 28 |
1 |
| 9 |
10791297 | The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate. | 2000 Jan-Feb |
1 |
| 10 |
9924498 | What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options. | 1999 Jan |
1 |
| 11 |
10363493 | [Treatment of Alzheimer's disease: acetylcholinesterase inhibitors]. | 1999 Apr |
2 |
| 12 |
10365643 | Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment. | 1999 Jun |
2 |
| 13 |
10622674 | Assessing the societal impact of acetylcholinesterase inhibitor therapies. | 1999 Nov |
1 |
| 14 |
9549662 | Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease. | 1998 Mar |
2 |
| 15 |
9585171 | Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study. | 1998 |
3 |
| 16 |
9718228 | The clinical trial protocol of the Metrifonate in Alzheimer's Trial (MALT). | 1998 |
2 |
| 17 |
9718229 | Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. | 1998 |
1 |
| 18 |
9720485 | Evaluating response to metrifonate. | 1998 |
3 |
| 19 |
9758325 | Seizures in patients receiving concomitant antimuscarinics and acetylcholinesterase inhibitor. | 1998 Sep-Oct |
1 |
| 20 |
9758555 | [Alzheimer disease. Irreversible AChE inhibition with metrifonate]. | 1998 Aug |
1 |
| 21 |
15616667 | Alzheimer's disease therapy - an update. | 1998 May |
1 |
| 22 |
9268605 | Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. | 1997 Jul |
1 |
| 23 |
8783813 | Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. | 1996 |
1 |
| 24 |
8876775 | Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease. | 1996 Fall |
2 |
| 25 |
7636741 | Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. | 1995 Aug |
2 |
| 26 |
1858789 | Stability of peripheral hematological parameters after chronic acetylcholinesterase inhibition in man. | 1991 Aug |
2 |
| 27 |
235931 | Mechanism of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate (Trichlorphon). | 1975 Mar 15 |
1 |